Creative Biolabs

Antibody-based pharmaceuticals resource

Science EN ↓ 594 episodes

Podcasts for antibody-based pharmaceuticals including Therapeutic antibody/Antibody-drug conjugates/vaccine/CAR-T/Immunotherapy. Creative-Biolabs, the provider, is an outsourced research organization for antibody-drug development.

Author

Creative Biolabs

Episodes

Complications After Allogeneic Stem Cell Transplantation 02.11.2022 13:08

Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column. 

The Endosomes and Self-Tolerance 02.11.2022 9:24

Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column. 

Breaking Immune Tolerance to Tumors 02.11.2022 8:47

Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column. 

Autoimmunity and T cell activation 02.11.2022 8:35

Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column. 

Chance and Challenge in Tumor Immunotherapy 02.11.2022 8:24

Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column. 

How To Make Transiently Redirected T Cells 02.11.2022 13:15

Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column. 

What Are the Related Technologies of T Cell Gene Transfer 02.11.2022 11:48

Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column. 

T Cell-Based Immunotherapy for Tumor 02.11.2022 9:04

Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column. 

Webinar: A Potent SARS-CoV-2 Neutralizing Single-domain Antibody (SdAb) Shows Therapeutic Efficacy in the Syrian Golden Hamster Model of COVID-19 27.10.2022 54:40

Creative Biolabs has invited Dr. James Naismith to walk us through the development process of his novel SARS-CoV-2 neutralising sdAbs and how his team has found a candidate demonstrating promising therapeutic efficacy in a hamster model of COVID-19.

Effector Functions-Enhanced Antibodies 21.10.2022 14:25

Enhancing the effector functions is one of the major strategies for the development of engineered monoclonal antibodies. Here, we will discuss the development of effector function-enhanced antibodies, and the solutions provided by Creative Biolabs.

Webinar-Development of Gene Therapy for Genetic Hearing Loss 21.10.2022 59:25

Creative Biolabs has invited Dr. Jeffrey R. Holt to walk us through how gene therapy has become a promising treatment for genetic hearing loss and how his team developed unique gene therapy strategies for genetic hearing loss.

Webinar-Optimal Therapeutic Intervention Timepoints for siRNA-Based Huntington's Disease Therapies 21.10.2022 56:02

Creative Biolabs has invited Dr. Markita Landry to walk us through how her team developed a near Infrared Catecholamine nanosensor (nIRCat) and used real-time imaging to find out what drives late-disease decreases in evoked dopamine release, and how to use these findings as optimal therapeutic intervention timepoints for siRNA-based Huntington's disease therapies.

The Injection Time and Dosage of the Dendritic Cell Vaccine 20.10.2022 10:10